New reverse transcriptase inhibitors.
Crowe
S
S
Macfarlane Burnet Centre for Medical Research, Fairfield, Victoria, Australia.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine / Q000494:pharmacology / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D019829:Nevirapine / Q000494:pharmacology / Q000627:therapeutic use; D063065:Organophosphonates; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use; D011355:Prodrugs / Q000494:pharmacology / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012999:Soman / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014498:Uracil / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine; D015224:Dideoxynucleosides; D054303:HIV Reverse Transcriptase; D019829:Nevirapine; D063065:Organophosphonates; D010078:Oxazines; D011355:Prodrugs; D018894:Reverse Transcriptase Inhibitors; D012999:Soman; D014498:Uracil; D000099227:Abacavir; C046573:pinacolyl methylphosphonic acid; C098320:efavirenz; C106812:adefovir dipivoxil; C083858:emivirine